SPECT/CT Imaging Device

The Department of the Interior Acquisition Services Directorate, on behalf of the National Institutes of Health National Cancer Institute Center for Cancer Research Molecular Imaging Branch, issued a Request for Information on SPECT/CT imaging device capabilities with a response deadline of 10:00 AM ET on August 6, 2026. This is market research only and does not constitute a binding obligation or promise to award a contract.

Respondents must submit company name, point of contact, SAM registration and UEI, written confirmation of capability to meet requirements, applicable NAICS code, company size standard, General Electric authorized reseller status, optional pricing, and socioeconomic status (Small Business, SDB, 8(a), HUBZone, SDVOSB, WOSB, VOSB, or other). The device must feature dual energy collimated CZT detectors, 12 detector ring design, deep learning-based image reconstruction, compatibility with MIM software for dosimetry planning, metal artifact reduction software, technology non-obsolescence protection, and Section 508 accessibility compliance. Delivery is required within 60 business days of award to the Molecular Imaging Branch in Rockville, Maryland. The period of performance runs from September 23, 2026, through September 22, 2027, under a firm-fixed-price structure. The Government reserves the right to consider small business set-asides under FAR 19.201 in subsequent procurement actions. Respondents bear all response costs.